Leonard D. Kohn

Q: What Schools Are Affiliated With Leonard D. Kohn

Leonard D. Kohn is affiliated with the following schools: Ohio University, University of Liège, Chiba University

Leonard D. Kohn's AcademicInfluence.com Rankings

Leonard D. Kohn

Philosophy

#6808

World Rank

#9911

Historical Rank

Logic

#3914

World Rank

#5142

Historical Rank

philosophy Degrees

Leonard D. Kohn

Biology

#9248

World Rank

#12432

Historical Rank

Endocrinology

#114

World Rank

#125

Historical Rank

Molecular Biology

#1242

World Rank

#1269

Historical Rank

Biochemistry

#1391

World Rank

#1515

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Leonard D. Kohn's Degrees

PhD Biochemistry University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Leonard D. Kohn Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Leonard D. Kohn's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pendrin, the protein encoded by the Pendred syndrome gene (PDS), is an apical porter of iodide in the thyroid and is regulated by thyroglobulin in FRTL-5 cells. (2000) (411)
Overexpression and overactivation of Akt in thyroid carcinoma. (2001) (300)
Genomic DNA Released by Dying Cells Induces the Maturation of APCs1 2 (2001) (265)
Geranylgeranylated Rho Small GTPase(s) Are Essential for the Degradation of p27Kip1 and Facilitate the Progression from G1 to S Phase in Growth-stimulated Rat FRTL-5 Cells* (1997) (254)
Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. (1996) (221)
Cloning, chromosomal assignment, and regulation of the rat thyrotropin receptor: expression of the gene is regulated by thyrotropin, agents that increase cAMP levels, and thyroid autoantibodies. (1990) (217)
Defect in Conversion of Procollagen to Collagen in a Form of Ehlers-Danlos Syndrome (1973) (212)
Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. (1999) (205)
The relationship of growth and adenylate cyclase activity in cultured thyroid cells: separate bioeffects of thyrotropin. (1983) (204)
The thyrotropin receptor. (1995) (201)
Procollagen peptidase: an enzyme excising the coordination peptides of procollagen. (1971) (196)
Calcium transport mechanisms in membrane vesicles from guinea pig brain synaptosomes. (1981) (182)
Thyroglobulin gene expression is regulated by insulin and insulin-like growth factor I, as well as thyrotropin, in FRTL-5 thyroid cells. (1987) (173)
Thyrotropin-ganglioside interactions and their relationship to the structure and function of thyrotropin receptors. (1976) (171)
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. (1982) (158)
Pendrin is an iodide-specific apical porter responsible for iodide efflux from thyroid cells. (2002) (154)
Expression of hypothalamic-pituitary-thyroid axis related genes in the human skin. (2002) (152)
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. (1983) (147)
Autoregulation of thyroid-specific gene transcription by thyroglobulin. (1998) (146)
Role of the Asialoglycoprotein Receptor in Binding and Entry of Hepatitis C Virus Structural Proteins in Cultured Human Hepatocytes (2003) (142)
Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. (1991) (137)
Wnt5a is expressed in murine and human atherosclerotic lesions. (2008) (134)
Localization of D-lactate dehydrogenase in native and reconstituted Escherichia coli membrane vesicles. (1975) (133)
Association of the changes in cytosolic Ca2+ and iodide efflux induced by thyrotropin and by the stimulation of alpha 1-adrenergic receptors in cultured rat thyroid cells. (1985) (129)
Interaction of Hepatitis C Virus-Like Particles and Cells: a Model System for Studying Viral Binding and Entry (2002) (125)
Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. (1992) (121)
The binding of thyrotropin to isolated bovine thyroid plasma membranes. (1973) (120)
Thyroid-specific expression and cyclic adenosine 3',5'-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. (1994) (114)
Thyrocytes express a functional toll-like receptor 3: overexpression can be induced by viral infection and reversed by phenylmethimazole and is associated with Hashimoto's autoimmune thyroiditis. (2005) (110)
Site-directed mutagenesis of a portion of the extracellular domain of the rat thyrotropin receptor important in autoimmune thyroid disease and nonhomologous with gonadotropin receptors. Relationship of functional and immunogenic domains. (1991) (108)
Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. (1993) (107)
Hypothyroidism in transgenic mice expressing IFN-γ in the thyroid (2000) (106)
Thyrotropin effects on thyroid cells in culture. Effects of trypsin on the thyrotropin receptor and on thyrotropin-mediated cyclic 3':5'-AMP changes. (1975) (106)
Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. (1976) (99)
Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion. (1975) (99)
Identification of separate determinants on the thyrotropin receptor reactive with Graves' thyroid-stimulating antibodies and with thyroid-stimulating blocking antibodies in idiopathic myxedema: these determinants have no homologous sequence on gonadotropin receptors. (1992) (98)
Characteristics of a solubilized thyrotropin receptor from bovine thyroid plasma membranes. (1975) (98)
Retention of pendrin in the endoplasmic reticulum is a major mechanism for Pendred syndrome. (2002) (96)
Mechanisms of active transport in isolated bacterial membrane vesicles. XV. Purification and properties of the membrane-bound D-lactate dehydrogenase from Escherichia coli. (1973) (95)
High basal levels of functional toll-like receptor 3 (TLR3) and noncanonical Wnt5a are expressed in papillary thyroid cancer and are coordinately decreased by phenylmethimazole together with cell proliferation and migration. (2007) (88)
Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes. (1976) (85)
Interaction of fragments B and C of tetanus toxin with neural and thyroid membranes and with gangliosides. (1980) (85)
Graves’ IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay (1982) (84)
Thyroglobulin interactions with thyroid plasma membranes. The existence of specific receptors and their potential role. (1979) (84)
Thymosin‐α1 regulates MHC class I expression in FRTL‐5 cells at transcriptional level (2000) (84)
Follicular thyroglobulin suppresses iodide uptake by suppressing expression of the sodium/iodide symporter gene. (1999) (83)
Identification of thyroid-stimulating antibody-specific interaction sites in the N-terminal region of the thyrotropin receptor. (1993) (83)
Regulation of thyrotropin receptor gene expression in rat FRTL-5 thyroid cells. (1992) (82)
A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. (1995) (82)
Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance. (1977) (82)
Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease. (1981) (81)
Cholera toxin inhibits interferon action. (1976) (80)
Sequence similarity between cholera toxin and glycoprotein hormones: implications for structure activity relationship and mechanism of action. (1976) (79)
Major histocompatibility complex class I gene expression in rat thyroid cells is regulated by hormones, methimazole, and iodide as well as interferon. (1992) (79)
Relationships of the structure and function of the interferon receptor to hormone receptors and establishment of the antiviral state. (1978) (78)
Thyroid Transcription Factor 1 Is Calcium Modulated and Coordinately Regulates Genes Involved in Calcium Homeostasis in C Cells (1998) (74)
Alpha 1-adrenergic stimulation of arachidonic acid release and metabolism in a rat thyroid cell line. Mediation of cell replication by prostaglandin E2. (1986) (74)
Thyroid-specific expression of cholera toxin A1 subunit causes thyroid hyperplasia and hyperthyroidism in transgenic mice. (1997) (74)
Prokaryotic expression of the thyrotropin receptor and identification of an immunogenic region of the protein using synthetic peptides. (1991) (74)
Characterization of the 5'-flanking region of the rat thyrotropin receptor gene. (1992) (74)
The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding. (1995) (73)
Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt5a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration (2009) (73)
Crystalline α2β2 Complexes of Tryptophan Synthetase of Escherichia coli A COMPARISON BETWEEN THE NATIVE COMPLEX AND THE RECONSTITUTED COMPLEX (1974) (71)
Delayed hypersensitivity in Graves' disease and exophthalmos: identification of thyroglobulin in normal human orbital muscle. (1977) (71)
Mechanism of iodide/chloride exchange by pendrin. (2004) (71)
An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. (1977) (69)
Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. (1997) (67)
Identification of thyroid transcription factor-1 in C cells and parathyroid cells. (1998) (67)
A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. (1994) (67)
Induction of TSH binding inhibitory immunoglobulins with the extracellular domain of human thyrotropin receptor produced using baculovirus expression system. (1993) (66)
Differential regulation of apical and basal iodide transporters in the thyroid by thyroglobulin. (2006) (66)
Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients. (1991) (66)
Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation. (1993) (66)
Phenyl Methimazole Inhibits TNF-α-Induced VCAM-1 Expression in an IFN Regulatory Factor-1-Dependent Manner and Reduces Monocytic Cell Adhesion to Endothelial Cells1 (2004) (66)
Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment. (1996) (63)
Role of MHC class I molecules in autoimmune disease. (1997) (63)
Regulation of FRTL-5 thyroid cell growth by phosphatidylinositol (OH) 3 kinase-dependent Akt-mediated signaling. (2001) (63)
The structure and function of glycoprotein hormone receptors: ganglioside interactions with human chorionic gonadotropin. (1976) (62)
Tryptophan residues of cholera toxin and its A and B protomers. Intrinsic fluorescence and solute quenching upon interacting with the ganglioside GM1, oligo-GM1, or dansylated oligo-GM1. (1981) (62)
Expression of PDS/Pds, the Pendred syndrome gene, in endometrium. (2002) (62)
Regulation of Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells (1997) (59)
Specific antibody to the thyrotropin receptor identifies multiple receptor forms in membranes of cells transfected with wild-type receptor complementary deoxyribonucleic acid: characterization of their relevance to receptor synthesis, processing, structure, and function. (1992) (59)
A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. (1996) (59)
Thyroid Gangliosides with High Affinity for Thyrotropin: Potential Role in Thyroid Regulation (1978) (58)
Effect of tetanus toxin on the accumulation of the permeant lipophilic cation tetraphenylphosphonium by guinea pig brain synaptosomes. (1979) (58)
Follicular Thyroglobulin (TG) Suppression of Thyroid-restricted Genes Involves the Apical Membrane Asialoglycoprotein Receptor and TG Phosphorylation* (1999) (57)
Tetanus toxin association with developing neuronal cell cultures. Kinetic parameters and evidence for ganglioside-mediated internalization. (1981) (56)
Phenylmethimazole blocks palmitate-mediated induction of inflammatory cytokine pathways in 3T3L1 adipocytes and RAW 264.7 macrophages. (2010) (56)
Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor. (1997) (56)
Thyroglobulin interactions with thyroid membranes. Relationship between receptor recognition of N-acetylglucosamine residues and the iodine content of thyroglobulin preparations. (1981) (56)
Characterization of monoclonal thyroid-stimulating and thyrotropin binding-inhibiting autoantibodies from a Hashimoto's patient whose children had intrauterine and neonatal thyroid disease. (1997) (56)
Genetic control of anti-thyrotropin receptor antibody generation in H-2K mice immunized with thyrotropin receptor-transfected fibroblasts. (1997) (56)
Effects of thyrotropin on the thyroid cell membrane: hyperpolarization induced by hormone-receptor interaction. (1977) (55)
Multicomponent structure of the thyrotropin receptor: relationship to Graves' disease. (1983) (55)
Effects of thyroglobulin and pendrin on iodide flux through the thyrocyte (2001) (54)
Relationships of thyrotropin to exophthalmic-producing substance. Purification of homogeneous glycoproteins containing both activities from [3H]-labeled pituitary extracts. (1970) (54)
In vivo expression of thyroid transcription factor-1 RNA and its relation to thyroid function and follicular heterogeneity: identification of follicular thyroglobulin as a feedback suppressor of thyroid transcription factor-1 RNA levels and thyroglobulin synthesis. (1999) (53)
The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating autoantibodies. (1991) (53)
Calf tendon procollagen peptidase: its purification and endopeptidase mode of action. (1974) (53)
Chapter 22. Relationships in the Structure and Function of Cell Surface Receptors for Glycoprotein Hormones, Bacterial Toxins, and Interferon (1977) (51)
Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: therapeutic implications. (1997) (51)
Thyrotropin regulation of cyclic adenosine monophosphate production in human coronary artery smooth muscle cells. (2000) (51)
Structure of an exophthalmos-producing factor derived from thyrotropin by partial pepsin digestion. (1975) (51)
Thyroid membrane ADP ribosyltransferase activity. Stimulation by thyrotropin and activity in functioning and nonfunctioning rat thyroid cells in culture. (1981) (50)
Newly Synthesized Rho A, Not Ras, Is Isoprenylated and Translocated to Membranes Coincident with Progression of the G1 to S Phase of Growth-stimulated Rat FRTL-5 Cells* (1998) (50)
Role of cysteine residues in the extracellular domain and exoplasmic loops of the transmembrane domain of the TSH receptor: effect of mutation to serine on TSH receptor activity and response to thyroid stimulating autoantibodies. (1992) (50)
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. (1985) (49)
The binding of ( 3 H)thyrotropin and an 3 H-labeled exophthalmogenic factor by plasma membranes of retro-orbital tissue. (1972) (49)
Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. (1992) (49)
Role of the cyclic adenosine 3',5'-monophosphate response element in efficient expression of the rat thyrotropin receptor promoter. (1992) (49)
The flavonoid quercetin regulates growth and gene expression in rat FRTL-5 thyroid cells. (2008) (49)
Methimazole prevents induction of experimental systemic lupus erythematosus in mice. (1994) (48)
The binding of thyrotropin to liposomes containing gangliosides. (1977) (47)
D-lactate dehydrogenase binding in Escherichia coli dld- membrane vesicles reconstituted for active transport. (1974) (46)
Characterization of fragment C and tetanus toxin binding to rat brain membranes. (1981) (46)
Monoclonal Antibody Studies Defining the Origin and Properties of Autoantibodies in Graves' Disease (1986) (45)
Hormonal regulation of major histocompatibility complex class I genes in rat thyroid FRTL-5 cells: thyroid-stimulating hormone induces a cAMP-mediated decrease in class I expression. (1992) (45)
The structure and function of glycoprotein hormone receptors: ganglioside interactions with luteinizing hormone. (1977) (45)
Use of thyrotropin receptor (TSHR) mutants to detect stimulating TSHR antibodies in hypothyroid patients with idiopathic myxedema, who have blocking TSHR antibodies. (1993) (44)
Enhanced adhesion of ligand‐conjugated biodegradable particles to colitic venules (2005) (44)
Thyrotropin interactions with human fat cell membrane preparations and the finding of soluble thyrotropin binding component. (1976) (44)
Binding and functional effects of thyroid stimulating hormone on human immune cells (1990) (44)
Glycosylation variants of human TSH selectively activate signal transduction pathways (1997) (43)
A Y-box protein is a suppressor factor that decreases thyrotropin receptor gene expression. (1996) (43)
Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. (2000) (43)
Regulation of prostaglandin synthesis by thyrotropin, insulin or insulin-like growth factor-I, and serum in FRTL-5 rat thyroid cells. (1991) (43)
Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin-dependent growth, and loss of thyrotropin receptor gene expression. (1990) (43)
Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole. (1998) (42)
A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment. (2012) (42)
Epitope heterogeneity of thyroid-stimulating antibodies predicts long-term outcome in Graves' patients treated with antithyroid drugs. (2003) (40)
Thyroglobulin (Tg) induces thyroid cell growth in a concentration-specific manner by a mechanism other than thyrotropin/cAMP stimulation. (2010) (40)
Dual mechanism of perturbation of thyrotropin-mediated activation of thyroid cells by antibodies to the thyrotropin receptor (TSHR) and TSHR-derived peptides. (1993) (40)
The prevalence and clinical significance of blocking thyrotropin receptor antibodies in untreated hyperthyroid Graves' disease. (2000) (40)
Tetanus toxin and thyrotropin interactions with rat brain membrane preparations. (1979) (39)
Separation of the glycoprotein and ganglioside components of thyrotropin receptor activity in plasma membranes. (1977) (39)
Single strand DNA-binding proteins and thyroid transcription factor-1 conjointly regulate thyrotropin receptor gene expression. (1995) (39)
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. (1999) (38)
Characteristics of a lysosomal membrane transport system for tyrosine and other neutral amino acids in rat thyroid cells. (1986) (38)
Polymeric particles conjugated with a ligand to VCAM‐1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis (2008) (38)
The kinetic properties of spinach leaf glyoxylic acid reductase. (1970) (38)
73-kDa heat shock cognate protein interacts directly with P27Kip1, a cyclin-dependent kinase inhibitor, during G1/S transition. (1999) (38)
Increases in cytosolic Ca++ down regulate thyrotropin receptor gene expression by a mechanism different from the cAMP signal. (1991) (37)
Periocular inflammation in mice with experimental systemic lupus erythematosus. A new experimental blepharitis and its modulation. (1995) (37)
Structure-function studies of cholera toxin and its A and B protomers. Modification of tryptophan residues. (1981) (37)
Graves’ Disease: A Host Defense Mechanism Gone Awry (2000) (37)
Iodide suppression of major histocompatibility class I gene expression in thyroid cells involves enhancer A and the transcription factor NF-kappa B. (1998) (36)
Role of phospholipids in the structure and function of the thyrotropin receptor. (1979) (36)
Relationship of gangliosides to the structure and function of thyrotropin receptors: their absence on plasma membranes of a thyroid tumor defective in thyrotropin receptor activity. (1976) (36)
Thyrotropin Receptor Autoantibodies (TSHRAbs): Epitopes, Origins and Clinical Significance (2003) (35)
The formation of thyrotropin receptor (TSHR) antibodies in a Graves' animal model requires the N-terminal segment of the TSHR extracellular domain. (1998) (35)
Characterization of the 70KDA component of the human Ku autoantigen expressed in insect cell nuclei using a recombinant baculovirus vector. (1990) (35)
Experimental exophthalmos. Binding of thyrotropin and an exophthalmogenic factor derived from thyrotropin to retro-orbital tissue plasma membranes. (1975) (35)
Characterization of an up-stream thyroid transcription factor-1-binding site in the thyrotropin receptor promoter. (1995) (35)
Relationship of thyrotropin to exophthalmos-producing substance. Formation of an exophthalmos-producing substance by pepsin digestion of pituitary glycoproteins containing both thyrotropic and exophthalmogenic activity. (1971) (34)
Thyroglobulin Repression of Thyroid Transcription Factor 1 (TTF-1) Gene Expression Is Mediated by Decreased DNA Binding of Nuclear Factor I Proteins Which Control Constitutive TTF-1 Expression (2000) (34)
The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation. (1994) (33)
Induction of autoimmunity by immunization of mice with human thyrotropin receptor. (1994) (33)
Dansylated thyrotropin as a probe of hormone-receptor interactions. (1979) (33)
Increased Wnt5a mRNA Expression in Advanced Atherosclerotic Lesions, and Oxidized LDL Treated Human Monocyte-Derived Macrophages (2012) (33)
Identification of a novel insulin-responsive element in the rat thyrotropin receptor promoter. (1994) (33)
Structure:function studies of receptors for thyrotropin and tetanus toxin: lipid modulation of effector binding to the glycoprotein receptor component. (1978) (32)
Thyroid growth immunoglobulins in large multinodular endemic goiters: effect of iodized oil. (1986) (32)
Increased cyclic adenosine 3',5'-monophosphate inhibits G protein-coupled activation of phospholipase C in rat FRTL-5 thyroid cells. (1996) (32)
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. (1982) (32)
Temperature‐Mediated Interaction of Tetanus Toxin with Cerebral Neuron Cultures: Characterization of a Neuraminidase‐Insensitive Toxin‐Receptor Complex (1983) (31)
Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Gene Expression in FRTL-5 Cells (1995) (31)
Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. (1999) (30)
The cAMP response element in the rat thyrotropin receptor promoter. Regulation by each decanucleotide of a flanking tandem repeat uses different, additive, and novel mechanisms. (1993) (30)
The contribution of subunits of thyroid stimulating hormone to the binding and biological activity of thyrotropin. (1974) (30)
Graves’ IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: A clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease (1983) (30)
Transforming growth factor-beta1 down-regulation of major histocompatibility complex class I in thyrocytes: coordinate regulation of two separate elements by thyroid-specific as well as ubiquitous transcription factors. (2000) (30)
Stimulation of adenylate cyclase activity in retro-orbital tissue membranes by thyrotropin and an exophthalmogenic factor derived from thyrotropin. (1975) (30)
Patients treated with interferon-alpha, interferon-beta, and interleukin-2 have a different thyroid autoantibody pattern than patients suffering from endogenous autoimmune thyroid disease. (1997) (30)
Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor. (1993) (29)
Insulin and insulin-like growth factor-I inhibit thyrotropin-increased iodide transport in serum-depleted FRTL-5 rat thyroid cells: modulation of adenosine 3',5'-monophosphate signal action. (1991) (29)
Characterization of lysosomal monoiodotyrosine transport in rat thyroid cells. Evidence for transport by system h. (1990) (28)
Role of insulin and serum on thyrotropin regulation of thyroid transcription factor-1 and pax-8 genes expression in FRTL-5 thyroid cells. (2000) (28)
Effect of hydrocortisone on the ability of thyrotropin to increase deoxyribonucleic acid synthesis and iodide uptake in FRTL-5 rat thyroid cells: opposite regulation of adenosine 3',5'-monophosphate signal action. (1990) (28)
Tartaric acid metabolism. V. Crystalline tartrate dehydrogenase. (1968) (28)
Thyrotropin effect on the availability of Ni regulatory protein in FRTL-5 rat thyroid cells to ADP-ribosylation by pertussis toxin. (1987) (27)
Thyrotropin-Mediated Repression of Class II Trans-Activator Expression in Thyroid Cells: Involvement of STAT3 and Suppressor of Cytokine Signaling1 (2003) (26)
In vivo and in vitro evidence for iodide regulation of major histocompatibility complex class I and class II expression in Graves' disease. (1996) (26)
Integrated steady state rate equations and the determination of individual rate constants. (1975) (26)
Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies. (1995) (26)
Thyrotropin receptors and gangliosides. (1980) (26)
Excess iodide decreases transcription of NIS and VEGF genes in rat FRTL-5 thyroid cells. (2010) (26)
Opposite regulation of deoxyribonucleic acid synthesis and iodide uptake in rat thyroid cells by basic fibroblast growth factor: correlation with opposite regulation of c-fos and thyrotropin receptor gene expression. (1992) (26)
Tartaric acid metabolism. 3. The formation of glyceric acid. (1968) (26)
Abnormal adenylate cyclase activity and altered membrane gangliosides in thyroid cells from patients with Graves' disease. (1977) (26)
A TSHr-LH/CGr chimera that measures functional TSAb in Graves' disease. (2012) (25)
Carrier-mediated transport of monoiodotyrosine out of thyroid cell lysosomes. (1989) (25)
Is type 2 diabetes an autoimmune-inflammatory disorder of the innate immune system? (2005) (25)
Retrobulbar modifications in experimental exophthalmos: the effect of thyrotropin and an exophthalmos producing substance derived from thyrotropin on the 35SO4 incorporation and glycosaminoglycan content of Harderian glands. (1973) (24)
The 90K protein increases major histocompatibility complex class I expression and is regulated by hormones, gamma-interferon, and double-strand polynucleotides. (2004) (24)
Effects of thyrotropin on iodine metabolism of dog thyroid cells in tissue culture. (1978) (24)
Major Histocompatibility Class II HLA-DRα Gene Expression in Thyrocytes: Counter Regulation by the Class II Transactivator and the Thyroid Y Box Protein. (1998) (24)
Binding of thyroglobulin to bovine thyroid membranes. Role of specific amino acids in receptor recognition. (1981) (24)
Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms. (2007) (24)
Thyrotropin receptor processing and interaction with thyrotropin. (1990) (23)
Thyroglobulin increases cell proliferation and suppresses Pax-8 in mesangial cells. (2001) (23)
Repeatedly passed FRTL-5 rat thyroid cells can develop insulin and insulin-like growth factor-I-sensitive cyclooxygenase and prostaglandin E2 isomerase-like activities together with altered basal and thyrotropin-responsive thymidine incorporation into DNA. (1990) (23)
Interferon-gamma suppresses thyrotropin receptor promoter activity by reducing thyroid transcription factor-1 (TTF-1) binding to its recognition site. (1996) (23)
Thyroglobulin: A Master Regulator of Follicular Function via Transcriptional Suppression of Thyroid Specific Genes (1999) (22)
In vitro synthesis of procollagen on polysomes. (1972) (22)
Thyrotropin upregulates alpha 1-adrenergic receptors in rat FRTL-5 thyroid cells. (1985) (22)
Role of pertussis toxin sensitive G proteins in the alpha 1 adrenergic receptor but not in the thyrotropin receptor mediated activation of membrane phospholipases and iodide fluxes in FRTL-5 thyroid cells. (1986) (22)
Tartaric acid metabolism. VII. Crystalline hydroxypyruvate reductase (D-glycerate dehydrogenase). (1968) (22)
Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure. (1994) (22)
Graves' disease following thyrotoxic painless thyroiditis. Analysis of antibody activities against the thyrotropin receptor in two cases. (1997) (21)
Wnt 5 a is expressed in murine and human atherosclerotic lesions (2008) (21)
Thyroglobulin gene activation by thyrotropin and cAMP in hormonally depleted FRTL-5 thyroid cells. (1986) (21)
Methimazole protects from experimental autoimmune uveitis (EAU) by inhibiting antigen presenting cell function and reducing antigen priming (2003) (21)
Thyrotropin regulation of malic enzyme in FRTL-5 rat thyroid cells. (1990) (21)
Interferon interactions with thyroid cells. (1982) (21)
A Novel Mouse Model of Graves’ Disease: Implications for a Role of Aberrant MHC Class II Expression in its Pathogenesis (2000) (21)
Cloning of the single strand DNA-binding protein important for maximal expression and thyrotropin (TSH)-induced negative regulation of the TSH receptor. (1996) (21)
Sequestration of tetanus toxin in developing neuronal cell cultures (1982) (20)
Propylthiouracil increases sodium/iodide symporter gene expression and iodide uptake in rat thyroid cells in the absence of TSH. (2012) (20)
Thyroglobulin Autoregulation of Thyroid-Specific Gene Expression and Follicular Function (2000) (20)
Ganglioside dependent return of TSH receptor function in a rat thyroid tumor with a TSH receptor defect. (1983) (20)
Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells. (2006) (19)
Existence of a soluble thyrotropin binding component in normal human sera. (1977) (19)
The structural properties of spinach leaf glyoxylic acid reductase. (1970) (19)
Chimeric studies of the extracellular domain of the rat thyrotropin (TSH) receptor: amino acids (268-304) in the TSH receptor are involved in ligand high affinity binding, but not in TSH receptor-specific signal transduction. (1993) (19)
Differing MHC class I requirements for induction and propagation of experimental systemic lupus erythematosus (1999) (19)
Class II transactivator suppresses transcription of thyroid-specific genes. (2000) (19)
Hashimoto's thyroiditis with heterogeneous antithyrotropin receptor antibodies: unique epitopes may contribute to the regulation of thyroid function by the antibodies. (2000) (18)
Purification and properties of D-lactate dehydrogenase from Escherichia coli ML 308-225. (1978) (18)
Immunochemical properties of the membrane-bound D-lactate dehydrogenase from Escherichia coli. (1975) (18)
Tartaric acid metabolism. IV. Crystalline L-malic dehydrogenase from Pseudomonas acidovorans. (1968) (18)
Adenylate cyclase activity of ν‐ras‐k transformed rat epithelial thyroid cells (1988) (18)
Phorbol Myristate Acetate Inhibits α1-Adrenergically but Not Thyrotropin-Regulated Functions in FRTL-5 Rat Thyroid Cells (1987) (18)
Gangliosides, the thyrotropin receptor, and autoimmune thyroid disease. (1984) (18)
Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells. (1993) (18)
Flow cytometric analyses of antibody binding to Chinese hamster ovary cells expressing human thyrotropin receptor. (1997) (18)
The RHL-1 subunit of the asialoglycoprotein receptor of thyroid cells: cellular localization and its role in thyroglobulin endocytosis (2003) (18)
CHAPTER 14 – The Thyrotropin Receptor* (1985) (17)
An Animal Model of Graves' Disease: Understanding the Cause of Autoimmune Hyperthyroidism (2004) (17)
The Ideal Quantum Gas (2001) (17)
MEMBRANE GLYCOLIPIDS AND THEIR RELATIONSHIP TO THE STRUCTURE AND FUNCTION OF CELL SURFACE RECEPTORS FOR GLYCOPROTEIN HORMONES, BACTERIAL TOXINS, AND INTERFERON (1978) (17)
Tartaric acid metabolism. VI. Crystalline oxaloglycolate reductive decarboxylase. (1968) (17)
Major histocompatibility class I gene transcription in thyrocytes: a series of interacting regulatory DNA sequence elements mediate thyrotropin/cyclic adenosine 3',5'-monophosphate repression. (2000) (17)
Structural changes caused by thyrotropin in thyroid cells and in liposomes containing reconstituted thyrotropin receptor. (1983) (17)
Methimazole regulation of thyroglobulin biosynthesis and gene transcription in rat FRTL-5 thyroid cells. (1991) (16)
Thyrotropin (TSH) receptor antibodies (TSHrAb) can inhibit TSH-mediated cyclic adenosine 3',5'- monophosphate production in thyroid cells by either blocking TSH binding or affecting a step subsequent to TSH binding. (1996) (16)
Graves' immunoglobulins activate phospholipase A2 by recognizing specific epitopes on thyrotropin receptor. (1999) (16)
Cell-free synthesis of procollagen: L-929 fibroblasts as a cellular model for dermatosparaxis. (1973) (16)
Spontaneous Autoimmune Disease in (NZB × NZW)F1 Mice is Ameliorated by Treatment with Methimazole (1998) (16)
Procollagen peptidase deficiency in a form of the Ehlers-Danlos syndrome. (1973) (16)
Receptors of the thyroid: the thyrotropin receptor is only the first violinist of a symphony orchestra. (1989) (15)
Regulation of Major Histocompatibility (MHC) Class II Human Leukocyte Antigen-DRα Gene Expression in Thyrocytes by Single Strand Binding Protein-1, a Transcription Factor That Also Regulates Thyrotropin Receptor and MHC Class I Gene Expression. (1998) (14)
Chapter 12 – Autoimmune Thyroid Disease Studied with Monoclonal Antibodies to the Thyrotropin Receptor (1983) (14)
Effect of the complex carbohydrate moiety on the structure of thyroglobulin. (1983) (14)
Phenyl methimazole suppresses dextran sulfate sodium-induced murine colitis. (2010) (14)
Tetanus toxin interactions with the thyroid: decreased toxin binding to membranes from a thyroid tumor with a thyrotropin receptor defect and in vivo stimulation of thyroid function. (1978) (14)
NEW PROCEDURES FOR DETECTING GRAVES' IMMUNOGLOBULINS (1985) (14)
Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy. (1998) (14)
High Glucose Levels Increase Major Histocompatibility Complex Class I Gene Expression in Thyroid Cells and Amplify Interferon-γ Action. (2002) (14)
Protein–Lipid Interactions of the Membrane-Penetrating MN-Glycoprotein from the Human Erythrocyte (1974) (13)
Increased major histocompatibility complex (MHC) expression in nontoxic goiters is associated with iodide depletion, enhanced ability of the follicular thyroglobulin to increase MHC gene expression, and thyroid autoantibodies. (2000) (13)
Asialoagalactothyroglobulin binds to the surface of human thyroid cells at a site distinct from the 'microsomal' autoantigen. (1984) (13)
Tartaric acid metabolism II. Crystalline protein converting meso-tartrate and dihydroxyfumarate to glycerate. (1966) (12)
Specificity of thyroglobulin interactions with thyroid cells and membranes. (1983) (12)
Monoclonal antibodies as probes of thyrotropin receptor structure (1984) (12)
Iodide, cytokines and TSH-receptor expression in Graves' disease. (2009) (12)
Phenylmethimazole inhibits production of proinflammatory mediators and is protective in an experimental model of endotoxic shock* (2012) (11)
Immunogenicity of a unique region of the human thyrotropin receptor (1993) (11)
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. (1982) (11)
Transformation of rat thyroid follicular cells stably transfected with cholera toxin A1 fragment. (1996) (11)
High frequency of T-cell lines responsive to immunodominant epitopes of thyrotropin receptor in healthy subjects. (1998) (11)
Thyrotropin stimulation of lysosomal tyrosine transport in rat FRTL-5 thyroid cells. (1988) (11)
Two Graves' disease patients who spontaneously developed hypothyroidism after antithyroid drug treatment: characteristics of epitopes for thyrotropin receptor antibodies. (1999) (11)
Control of the thyroid gland: regulation of its normal function and growth. March 20-21, 1989, Bethesda, Maryland. Proceedings. (1990) (11)
Bovine thyroglobulin. 27 S iodoprotein interactions with thyroid membranes and formation of a 27 S iodoprotein in vitro. (1982) (11)
Regulatory CD8+ T cells control thyrotropin receptor-specific CD4+ clones in healthy subjects. (2003) (11)
Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding. (1994) (11)
Regulation of major histocompatibility complex gene expression in thyroid epithelial cells by methimazole and phenylmethimazole. (2010) (11)
A sandwich ELISA for the detection of Wnt5a. (2010) (11)
The synthesis and secretion of thyroid hormones: regulation by multiple hormones and signals which can be subverted by autoantibodies to the thyrotropin receptor (1994) (10)
Regulation of geranylgeranyl pyrophosphate synthase in the proliferation of rat FRTL-5 cells: involvement of both cAMP-PKA and PI3-AKT pathways. (2004) (10)
TGF-β-like Transcriptional Effects of Thyroglobulin (Tg) in Mouse Mesangial Cells (2007) (9)
Thyrotropin increases malic enzyme messenger ribonucleic acid levels in rat FRTL-5 thyroid cells. (1989) (9)
Interferon and glycoprotein hormones. (1977) (9)
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (Mac-2BP) protein. (2007) (9)
Tartaric Acid Metabolism (2003) (8)
Major histocompatibility class II HLA-DR alpha gene expression in thyrocytes: counter regulation by the class II transactivator and the thyroid Y box protein. (1998) (8)
Membrane alterations following interferon treatment. (1978) (8)
Structural, kinetic, and renaturation properties of an induced hydroxypyruvate reductase from Pseudomonas acidovorans. (1975) (8)
Receptor structure and function: an exploratory approach using the thyrotropin receptor as a vehicle. (1982) (8)
Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor. (1997) (8)
Characterization of the Thyrotropin Receptor and Its Involvement in Exophthalmos (1975) (8)
Control of the Thyroid Gland (1989) (8)
A microsequencing approach to identify proteins which appear to interact with thyrotropin in rat FRTL-5 thyroid cells. (1990) (7)
Hashimoto's thyroiditis with a monoclonal antithyroglobulin autoantibody: disappearance of the monoclonal antibody after thyroidectomy. (1988) (6)
TGF-beta-like transcriptional effects of thyroglobulin (Tg) in mouse mesangial cells. (2007) (6)
The Structure of the Thyrotropin (TSH) Receptor: Potential Role of Gangliosides and Relationship to Receptors for Interferon and Bacterial Toxins (1981) (6)
Renaturation of spinach leaf glyoxylic acid reductase. (1970) (6)
Cloning and characterization of the 4.2 kb region of the rat thyrotropin receptor promoter. (1997) (6)
Interaction of the thyrotropin receptor on rat FRTL-5 thyroid cells with thyrotropin and a thyrotropin-stimulating autoantibody from Graves' patients. (1987) (5)
The arachidonic acid signal system in the thyroid: regulation by thyrotropin and insulin/IGF-I. (1989) (5)
Co-expression of the CD8 receptor in a human CD4+ T-cell clone influences proliferation, cytosolic Ca2+ release and cytokine production. (2002) (5)
The effect of posttranslational modifications on the in vitro activity of recombinant human thyroid-stimulating hormone. (2003) (5)
[59] Hydroxypyruvate reductase (d-glycerate dehydrogenase) from Pseudomonas (1982) (5)
Monoclonal Antibodies and the Thyrotropin Receptor (1984) (4)
High glucose levels increase major histocompatibility complex class I gene expression in thyroid cells and amplify interferon-gamma action. (2002) (4)
Nature of Thyroid Autoantigens: The TSH Receptor (1987) (4)
Localization of gene encoding the thyroid stimulating hormone receptor (Tshr) on mouse Chromosome 12 (1996) (3)
[48] l- and mesotartaric acid dehydrogenase (crystalline) (1966) (3)
Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression. (1998) (3)
Thyrotropin receptor autoantibodies in thyroid autoimmune disease: Epitopes and origin (1992) (3)
Relationship of thyrotropin to exophthalmos-producing substance: formation of an exophthalmos-producing factor by pepsin digestion of mouse pituitary tumor and human thyrotropin preparations. (1975) (3)
Affinity chromatography of thyrotropin receptors and antibody. (1974) (3)
Effects of cycloheximide and tunicamycin on lysosomal cystine transport in rat FRTL-5 cells. (1993) (2)
Phenylmethimazole blocks palmita te-mediated induction of inflammatory cytokine pathways in 3 T 3 L 1 adipocytes and RAW 264 . 7 macrophages (2010) (2)
Sulfhydryl studies of spinach leaf glyoxylic acid reductase. (1970) (2)
Hydroxypyruvate reductase (D-glycerate dehydrogenase) from Pseudomonas. (1982) (2)
Thyroglobulin Interactions with Thyroid Plasma Membranes (2002) (2)
Selective binding of thyrotropin receptor autoantibodies to recombinant extracellular domain of thyrotropin/lutropin-chorionic gonadotropin receptor chimeric proteins. (1999) (2)
Regulation of thyroglobulin (Tg) iodination and thyroid hormone formation in FRTL-5 cells (1986) (2)
Thyroglobulin--a new cyclic adenosine monophosphate-dependent protein kinase? (1995) (2)
Modulation of experimental systemic lupus erythematosus. (1996) (2)
[46] Hydroxypyruvate reductase (d-glycerate dehydrogenase; crystalline) Pseudomonas (1966) (2)
Coexistence of Cushing Syndrome From Functional Adrenal Adenoma and Addison Disease From Immune-Mediated Adrenalitis (2012) (2)
Crystalline alpha2 beta2 complexes of tryptophan synthetase of Escherichia coli. A comparison between the native complex and the reconstituted complex. (1974) (2)
Monocytic Cell Adhesion to Endothelial Cells Factor-1-Dependent Manner and Reduces VCAM-1 Expression in an IFN Regulatory-Induced α Phenyl Methimazole Inhibits TNF - (2004) (2)
Binding of Thyroglobulin to Bovine Thyroid Membranes (2001) (1)
Exophthalmogenic activity of the beta subunit of thyrotropin. (1975) (1)
A pre-Golgi membrane-bound form of thyroglobulin (TG) contains mannose phosphate and tetraiodothyronine (T4) (1988) (1)
Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer (2012) (1)
The Cloning Road to the TSH Receptor and Autoimmune Graves’ Disease (1990) (1)
Experimental exophthalmos. Alterations of normal hormone-receptor interactions in the pathogenesis of a disease. (1974) (1)
Nicotinamide potentiates TSHR and MHC class II promoter activity in FRTL-5 cells (1999) (1)
[Thyroid-stimulating immunoglobulins. The related antigens]. (1982) (1)
Structure and Regulated Expression of the TSH Receptor Gene: Differences and Similarities to Gonadotropin Receptors (1994) (1)
Thyroglobulin interaction with thyroid membranes: implications for regulation of thyroid hormone formation (1985) (1)
[Anti-thyrotropin (TSH) receptor antibody binding epitopes of TSH receptor: site-directed mutagenesis approach]. (1994) (1)
Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor. (2008) (1)
Thyrotropin Receptor Signaling (2003) (0)
Influence of tetanus toxin on synaptic plasma membrane calcium transport (1981) (0)
Phorbol myristate acetate inhibits alpha 1-adrenergically but not thyrotropin-regulated functions in FRTL-5 rat thyroid cells. (1987) (0)
Thyrotropin interaction with high-density lipoproteins. (1985) (0)
Growth, freezing and in situ assay of cells cultured. (2001) (0)
Thyrotropin Receptor: Characterization and Purification (1990) (0)
Mono clonal antibodies as probes for ligand receptor interactions studies of the thyrotropin receptor (1981) (0)
[Action of gamma globulins isolated from the serum of exophthalmic patients on the binding of thyrotropin and its exophthalmic derivative to membrane receptors from retro-ocular tissue]. (1973) (0)
The Kinetic Properties of Spinach Leaf (2003) (0)
PRESENCE OF THYROID GROWTH PROMOTING ANTIBODY IN PATIENTS WITH HASHIMOTO'S THYROIDITIS: EFFECT OF LONG-TERM THYROXINE TREATMENT (1987) (0)
ENZYMATIC CONVERSION OF PHOSPHATIDYLETHANOLAMINE TO PHOSPHATIDYLCHOLINE BY S-ADENCSYL-l-METHIONINE DEPENDENT TRANSMETHYLASES IN BOVINE THYROID (1981) (0)
INTRINSIC FLUORESCENCE AND SOLUTE QUENCHING UPON INTERACTING WITH THE GANGLIOSIDE (2001) (0)
Characterization of the thyrotropin receptor and its involvement in Graves' disease. (1977) (0)
THS receptor mediated growth of thyroid cells: mechanism and relation to autoimmune thyroid diseases (1984) (0)
INVOLVEMENT OF TRYPTOPHAN IN THE BINDING SITE OF THE B PROTOMER OF CHOLERA TOXIN (1981) (0)
Abstract 1932: Phenylmethimazole decreases constitutively high basal levels of Interleukin 6 (IL-6) in a triple negative breast cancer cell line (2012) (0)
The neutral aminoacid carrier in thyroid lysosomes: Hormonal regulation and inhibition by a photo-activatable substrate analogue (1988) (0)
Exophthalmogenic Activity of the β Subunit of Thyrotropin (1975) (0)
The Classical Gas in the Canonical Formalism (2001) (0)
Thyrotropin upregulates a 1-adrenergic receptors in rat FRTL-5 thyroid cells ( iodide transport / thyroglobulin / thyroid hormone / arachidonic acid / prazosin ) (0)
[Relations existing between thyroid-stimulating hormone and exopthalmic factor of the pituitary]. (1969) (0)
Toll-like receptor 3 in pancreatic cancer and malignant melanoma: a new paradigm for treatment (2008) (0)
Antibodies to the Thyrotropin (TSH) Receptor and Autoimmune Thyroid Disease (1989) (0)
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells (2000) (0)
The TSH receptor in autoimmune Basedow's disease. (2009) (0)
Cancer Therapy : Preclinical Phenylmethimazole Decreases Toll-Like Receptor 3 and Noncanonical Wnt 5 a Expression in Pancreatic Cancer and Melanoma Together with Tumor Cell Growth and Migration (2009) (0)
Procollagen Peptidase : Peptides of Procollagen An Enzyme Excising the Coordination (0)
Photoaffinity labeling of lysosomal membrane proteins with [125I]diiodotyrosine, a system h ligand. (1995) (0)
Thyrotropin regulation of thyroid cell functions: mechanisms and relationship to thyroid disease. (1988) (0)
Relationships of Thyrotropin to Exophthalmic- producing Substance P~:RII~ICATIO~ OF HOMOGEFEOUS GLYCOPROTEIKS COT\‘TAII\‘IP\TG BOTH ACTIVITIES FROM [3H]- LABELED PITUITARY EXTRACTS (2003) (0)
Monoclonal antibodies to the thyrotropin (TSH) receptor in the study of graves' disease: Idiotypes and antiidiotypes (1986) (0)
Monoclonal Antibodies to the thyrotropin (TSH) receptor in the studies of Graves' disease (1986) (0)
MS129 WNT5A EXPRESSION IN HUMAN ATHEROSCLEROTIC PLAQUES IS ELEVATED IN MACROPHAGE-RICH AND COMPLICATED PLAQUES (2010) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Leonard D. Kohn?

Leonard D. Kohn is affiliated with the following schools:

Leonard D. Kohn's Academic­Influence.com Rankings

Leonard D. Kohn's Degrees

Why Is Leonard D. Kohn Influential?

Leonard D. Kohn's Published Works

Published Works

What Schools Are Affiliated With Leonard D. Kohn?

Leonard D. Kohn's AcademicInfluence.com Rankings